Skip to main content
Clinical Trials/IRCT2014102919716N4
IRCT2014102919716N4
Completed
Phase 2

Effect of single dose Phenobarbital on treatment of term and near term newborn'shyper bilirubinemia admitted in the hospital

orth Khorasan University of Medical Sciences0 sites30 target enrollmentStarted: TBDLast updated:

Overview

Phase
Phase 2
Status
Completed
Sponsor
orth Khorasan University of Medical Sciences
Enrollment
30

Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
1 day to 7 days (—)
Sex
All

Inclusion Criteria

  • Term and near\-term babies (\> 35 week) or (\> 2500 g) with serum bilirubin levels in the therapeutic range (\> 15 mg / dl) who admitted in hospital without signs of hemolysis, internal bleeding, G6PD, sepsis, severe respiratory illness requiring mechanical ventilation and congenital anomalies are enrolled after parental consent.

Exclusion Criteria

  • Not provided

Investigators

Sponsor
orth Khorasan University of Medical Sciences

Similar Trials